Developing high-resolution metastasis signatures for improved cancer prognosis using single-cell RNA sequencing data:A case study in lung adenocarcinoma

Author:

Zhou Yeman1,Li Hanlin1,Zhang Cheng1,Yu De’en1,Yang Heng1,Wang Chunping2,Zhang Youhua3,Deng Wensheng1,Li Bo1,Zhang Shihua1

Affiliation:

1. Wuhan University of Science and Technology

2. Wuhan Haidian Foreign Language Shiyan School

3. Anhui Agricultural University

Abstract

Abstract Background Metastasis remains the reason for high cancer mortality and it is a valuable predictive factor in cancer prognosis. Single-cell RNA sequencing (scRNA-seq) can reveal cellular heterogeneity in metastasis microenvironment and capture high-resolution signatures for improved cancer prediction. Methods An integrated analysis framework was designed for metastatic lung adenocarcinoma (LUAD) scRNA-seq profiles and we identified 9 key prognostic genes (KPGs) that were trained and validated in 407 internal and external patient cohorts using Lasso-Cox method and Receiver Operating Characteristic (ROC) curves. To ensure the predictive stability of the KPGs signatures, 10 random samples of data from the TCGA cohort were taken. Correlation analysis revealed the strong association between KPGs signatures and several clinical characteristics such as gender, T-stage, and N-stage. We incorporated these risk clinical variables into a KPGs nomogram model. Results The results based on ROC curves and calibration curves show that the KPGs nomogram model with superior accuracy for overall survival (OS) prediction. We also found that high risk group with high nomogram scores had poorer prognosis accompanied by a higher tumor mutation burden (TMB) and it was associated with the upregulation of cell cycle, DNA replication, ECM receptor interaction, P53 signaling pathway, spliceosome and proteasome pathway. Conclusions Mining single-cell resolution metastatic features from scRNA-seq data to improve cancer prognosis is a viable strategy that would be a useful tool in risk gene discovery and targeted therapy in metastatic cancers.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3